DMEM/F-12, HEPES
DMEM/F-12, HEPES
Gibco™

DMEM/F-12, HEPES

DMEM/F-12 (medio Eagle modificado de Dulbecco/mezcla de nutrientes F-12) se utiliza ampliamente como un medio basal para fomentar el crecimientoMás información
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
11330032500 mL
1133005710 x 500 mL
113300995 L
1133010710 L
Número de catálogo 11330032
Precio (CLP)
47.643
Each
Añadir al carro de la compra
Cantidad:
500 mL
Customize this product
Precio (CLP)
47.643
Each
Añadir al carro de la compra
DMEM/F-12 (medio Eagle modificado de Dulbecco/mezcla de nutrientes F-12) se utiliza ampliamente como un medio basal para fomentar el crecimiento de diferentes células de mamíferos. Las células cultivadas con éxito en DMEM/F-12 incluyen MDCK, células gliales, fibroblastos, células endoteliales humanas y fibroblastos de rata. Ofrecemos una gran variedad de modificaciones de DMEM/F-12 para diversas aplicaciones de cultivos celulares. Busque la formulación adecuada mediante la herramienta de selección de medios.

Este DMEM/F-12 se ha modificado de la manera siguiente:
Con
• L-glutamina
• Ácido 4-(2-hidroxietil)piperazin-1-iletanosulfónico (HEPES)
• Rojo de fenol

Está disponible la formulación completa.

Uso de DMEM/F-12
DMEM/F-12 es una mezcla en proporción 1:1 de DMEM y Ham F-12. Esta formulación combina las altas concentraciones de glucosa, aminoácidos y vitaminas de DMEM con la amplia variedad de componentes de F-12. DMEM/F-12 no contiene proteínas, lípidos ni factores de crecimiento. Por lo tanto, el DMEM/F-12 podría requerir una suplementación, normalmente con un 10 % de suero fetal bovino (SFB). DMEM/F-12 utiliza un sistema de tampones de bicarbonato sódico y, por lo tanto, requiere un ambiente con un 5–10 % de CO2 para mantener el pH fisiológico.

Sistema de fabricación y calidad conforme a las buenas prácticas de fabricación actuales
El DMEM/F-12 se fabrica en unas instalaciones que cumplen con las buenas prácticas de fabricación actuales ubicadas en Grand Island, Nueva York (EE. UU). Las instalaciones se han registrado en la Agencia estadounidense de alimentos y medicamentos (FDA) como fabricante de dispositivos médicos y tienen la certificación según la norma ISO 13485. Para la continuidad de la cadena de suministro, podemos ofrecer un producto DMEM/F-12 idéntico fabricado en nuestras instalaciones de Escocia (31330-038). Estas instalaciones también están registradas en la Agencia estadounidense de alimentos y medicamentos (FDA), calificadas como punto de fabricación de dispositivos médicos y están certificadas según la norma ISO 13485.

Para su uso en investigación o procesos de fabricación posteriores. No apto para uso diagnóstico ni para la administración directa en seres humanos ni en animales.

Especificaciones
Línea de célulasMDCK, células gliales, fibroblastos, células endoteliales humanas y fibroblastos de rata
Concentración1 X
Para utilizar con (aplicación)Cultivo de células de mamíferos
Calidad de fabricacióncGMP-compliant under the ISO 13485 standard
Línea de productosGibco
Tipo de productoDMEM (medio Eagle modificado de Dulbecco)/F-12
Cantidad500 mL
Duración de almacenamiento12 meses a partir de la fecha de fabricación
Condiciones de envíoTemperatura ambiente
ClasificaciónLibre de material de origen animal
FormularioLíquido
Serum LevelSuplementos de suero estándar
EsterilidadEstéril con filtro
Sterilization MethodEstéril con filtro
Con aditivosAlto contenido en glucosa, Glutamina, Ácido 4-(2-hidroxietil)piperazin-1-iletanosulfónico (HEPES), Rojo de fenol, Piruvato sódico
Unit SizeEach
Contenido y almacenamiento
Condiciones de almacenamiento: De 2 °C a 8 °C (proteger de la luz)
Condiciones de envío: Ambiente
Vida útil: 12 meses a partir de la fecha de fabricación

Preguntas frecuentes

The lids of DMEM/F-12, HEPES medium (Cat. No. 31330038, 11330032, 31330095, 11330057, 11330107) have a different color now. Have there been any changes in the composition of the medium?

The color change of the lid has no effect on the sterility or functionality of the product. There has been no change to the end product DMEM/F-12, HEPES medium (Cat. No. 31330038, 11330032, 31330095, 11330057, 11330107); the medium still has the same composition.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Do you offer DMEM/F12 medium without folic acid?

We do not offer DMEM/F12 medium without folic acid as a standard catalog product. However, our Customs group can make it for you as a custom media. If you are interested, please complete this Custom order inquiry form PDF (https://www.thermofisher.com/content/dam/LifeTech/global/applied-sciences/pdfs/Bioproduction/Gibco-Custom-Media-Buffers-Request-Form.pdf) and email it to custommedia@thermofisher.com. Our Customs group will review your requirements and get back to you within a couple of days with pricing, ordering information, and lead time. After that, you have the choice of proceeding with an “official” order or declining.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

What is the shelf life of the DMEM, high glucose, pyruvate medium once the bottle is opened and the medium is supplemented?

We do not provide stability data for the product once it is opened as it would depend on the usage and storage conditions.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Is it necessary to store DMEM, high glucose, pyruvate medium in the dark?

Yes, the medium should be stored in the dark because there are some components in the medium such as HEPES, Tryptophan, and Riboflavin, etc. that are sensitive to light.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

How long can I keep my media after supplementing with serum?

Generally speaking, media can be used for up to three weeks after supplementation with serum. There are no formal studies to support this, but it is the rule of thumb used by our scientists.

Find additional tips, troubleshooting help, and resources within our Mammalian Cell Culture Basics Support Center.

Citations & References (5)

Citations & References
Abstract
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy
Authors:Meghan Logun, Xin Wang, Yusha Sun, Stephen J Bagley, Nannan Li, Arati Desai, Daniel Y Zhang, MacLean P Nasrallah, Emily Ling-Lin Pai, Bike Su Oner, Gabriela Plesa, Donald Siegel, Zev A Binder, Guo-Li Ming, Hongjun Song, Donald M O'Rourke
Journal:Cell Stem Cell
PubMed ID:39657679
Patient-derived tumor organoids have been leveraged for disease modeling and preclinical studies but rarely applied in real time to aid with interpretation of patient treatment responses in clinics. We recently demonstrated early efficacy signals in a first-in-human, phase 1 study of dual-targeting chimeric antigen receptor (CAR)-T cells (EGFR-IL13Rα2 CAR-T cells) ... More
Fabrication of synthetic polymer coatings and their use in feeder-free culture of human embryonic stem cells.
Authors:Nandivada H, Villa-Diaz LG, O'Shea KS, Smith GD, Krebsbach PH, Lahann J,
Journal:Nat Protoc
PubMed ID:21720316
The culture of human embryonic stem (hES) cells in defined and xenogeneic-free conditions will contribute substantially to future biotechnological and medical applications. To achieve this goal, we developed the first fully defined synthetic polymer coating poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide] (PMEDSAH) that sustains long-term growth of hES cells in different culture media. ... More
Insulin and insulin-like growth factor I receptors utilize different G protein signaling components.
Authors:Dalle S, Ricketts W, Imamura T, Vollenweider P, Olefsky JM,
Journal:J Biol Chem
PubMed ID:11278773
We examined the role of heterotrimeric G protein signaling components in insulin and insulin-like growth factor I (IGF-I) action. In HIRcB cells and in 3T3L1 adipocytes, treatment with the Galpha(i) inhibitor (pertussis toxin) or microinjection of the Gbetagamma inhibitor (glutathione S-transferase-betaARK) inhibited IGF-I and lysophosphatidic acid-stimulated mitogenesis but had no ... More
Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells.
Authors:Scheffers MS, van der Bent P, Prins F, Spruit L, Breuning MH, Litvinov SV, de Heer E, Peters DJ,
Journal:Hum Mol Genet
PubMed ID:11063733
Polycystin-1 is a novel protein predicted to be a large membrane-spanning glycoprotein with an extracellular N-terminus and an intracellular C-terminus, harboring several structural motifs. To study the subcellular localization, antibodies raised against various domains of polycystin-1 and against specific adhesion complex proteins were used for two-color immunofluorescence staining. In Madine ... More
alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells.
Authors: Ahn Bong-Hyun; Rhim Hyangshuk; Kim Shi Yeon; Sung Young-Mo; Lee Mun-Yong; Choi Ju-Youn; Wolozin Benjamin; Chang Jong-Soo; Lee Young Han; Kwon Taeg Kyu; Chung Kwang Chul; Yoon Shin-Hee; Hahn Sang June; Kim Myung-Suk; Jo Yang-Hyeok; Min Do Sik;
Journal:J Biol Chem
PubMed ID:11821392
alpha-Synuclein has been implicated in the pathogenesis of many neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease. Although the function of alpha-synuclein remains largely unknown, recent studies have demonstrated that this protein can interact with phospholipids. To address the role of alpha-synuclein in neurodegenerative disease, we have investigated whether it ... More